FOSUN HEALTH Logo

Heart Failure Diagnosis

catalogue

Heart Failure Diagnosis

Heart Failure Diagnosis

The diagnosis of heart failure is made twice: first as a suspicion, from the story and the examination, and then as a definition, from an echocardiogram. Everything between those two points is a small number of tests, each chosen because a particular question is still open — whether this is heart failure at all, which phenotype it is, what is causing it, and how congested and how well perfused the patient is today. This page takes each test in turn and sets out what its result actually changes, which is more useful to know than what the test is called.

The first question: is this heart failure at all?

The opening move is not a scan. It is a careful history — what brings the breathlessness on, what makes the swelling better, how many pillows are needed, what the weight has done — and an examination that looks for the signs the story predicts: raised neck veins, crackles at the lung bases, swelling that pits, a heart whose beat can be felt displaced to the left. Between them, these two steps do more diagnostic work than any single test, and they also generate the alternative explanations that need to be considered.

A natriuretic peptide blood test is used alongside them, and it is worth being precise about what it is good for. The heart releases these peptides when its walls are stretched, so the level is a marker of strain rather than a definition of the disease. Its greatest value is in an untreated patient whose breathlessness has another possible explanation: a normal level makes heart failure unlikely, and sends the assessment down a different road. A raised level is much less specific — age, kidney function, atrial fibrillation, infection and obesity all move it — so it points towards the heart rather than settling the matter.

Use it as a rule-out test, not as a score. The peptide level is not a measure of how severe the heart failure is, and it is not something to track daily at home as a way of judging the week. A single high value in an unwell patient tells the team to look harder at the heart; a normal value in someone who is not yet treated tells them to look elsewhere. Do not ask for it as a reassurance test when the patient is stable and well treated — that is the setting in which it is least informative.

Echocardiography: the test that defines the diagnosis

The echocardiogram is the centre of the assessment, because it is the point at which "heart failure" becomes a specific condition with a specific treatment. It is painless, takes a few minutes, and reports several separate things, each of which changes a decision on its own.

What the report gives What it means What it changes
Ejection fraction The proportion of the blood in the ventricle pushed out with each beat, as a percentage It sorts the patient into the reduced, mildly reduced or preserved phenotype, and with that decides which treatments are candidates
Chamber size and wall thickness Whether the ventricle is dilated, and whether its walls have thickened in response to pressure It separates an overloaded heart from a weakened one, and points towards hypertension or valve disease as the driver
Wall motion Whether every segment of muscle contracts, and whether any segment moves abnormally or looks scarred A segment that does not move suggests an old infarction; a segment that moves poorly but is not scarred may recover once it is given blood
Valve function How each valve opens and closes — stenosis, regurgitation, and their severity A valve problem that is severe may be the cause rather than a consequence, and treating it may change the whole plan
Filling pressures and the right heart The estimated pressures the heart fills against, the size of the left atrium, and how the right ventricle is coping It explains a patient whose squeeze looks reasonable and who is still breathless — the picture behind a preserved ejection fraction

Two limitations are worth knowing before reading the number too closely. The ejection fraction depends on the conditions of the moment — blood pressure, how much fluid is on board, and the medicines being taken — so it is not the same measurement twice. And a normal ejection fraction at rest does not exclude heart failure: in the preserved phenotype the ventricle can squeeze well and still be stiff and slow to relax, which is why some patients are assessed again during exercise, when the abnormality has somewhere to show itself. Repetition of the echo is therefore driven by a question — a change in symptoms, a change in treatment, a decision about a device — rather than by the calendar.

Electrocardiogram and chest X-ray: the two-minute tests

The electrocardiogram is the cheapest test in the pathway and the one that most often redirects it. It is read for four things. The rhythm — whether atrial fibrillation or another sustained arrhythmia is present, because a fast irregular rhythm can both cause and worsen a failing pump. The conduction — how long the electrical signal takes to cross the ventricle, because a wide QRS means the two sides are contracting out of step, and that is the observation on which cardiac resynchronisation depends. The trace of an old infarction — a Q wave in a territory of muscle that no longer contracts, which explains the pump's weakness without any further history. And the evidence of strain from pressure overload — the voltage patterns of a thickened ventricle.

The chest X-ray answers a different question, and answers it in a way no other test does: it shows the size of the heart and the state of the lungs at the same moment. Congestion in the lungs, fluid in the pleural space and an enlarged heart silhouette are all visible, and so are the competing explanations — a pneumonia, a collapsed lung, a mass. Its limits are just as clear: it cannot measure the ejection fraction, it cannot see the valves, and a normal-looking X-ray in a patient with chronic heart failure is entirely possible. It is used because it is immediate, and because it looks at the chest from a different angle than the echo does.

The blood tests that change management

Once the phenotype is known, a short panel of bloods becomes part of the treatment plan rather than part of the diagnosis, because the medicines that treat heart failure are given against kidney function and potassium, and several treatable contributors are found only in a laboratory. That is why the drug plan and the blood panel move together: a result is not collected for the record, it is collected because it sets a dose, rules out a cause, or identifies something worth correcting.

Test What is looked for What it changes
Kidney function Creatinine and the estimated filtration rate It sets the starting dose and the ceiling for several of the heart failure medicines, and it is the reason doses are checked after each increase
Potassium and sodium Whether potassium is too high or too low, and whether sodium is low Potassium safety governs the mineralocorticoid receptor antagonist and the diuretic; a low sodium is a marker of how much fluid is on board
Full blood count Haemoglobin and the blood's other cell lines Anaemia both causes breathlessness and makes heart failure harder to manage; it is treated when found rather than accepted
Iron studies Ferritin and transferrin saturation Iron deficiency is common in heart failure, is often present without anaemia, and is treatable — which is why it is looked for deliberately rather than incidentally
Thyroid function An overactive or underactive thyroid Both can weaken the pump and disturb the rhythm, and both are reversible, so the test is part of the standard panel
Troponin Whether there is ongoing injury to the muscle It directs attention to the coronary arteries or to an active inflammatory process rather than to fluid alone

Finding what is driving it

A phenotype is a description, not an explanation. The next stage is to establish which of the several routes to a failing pump this patient is on, because the answer decides whether a procedure, a specific drug, or a change in habit belongs in the plan. The causes page sets out the routes themselves; what follows is how each is looked for.

Coronary disease is looked for actively in most patients, because it is the commonest route and one of the few that a procedure can change. Depending on the patient's history and fitness, that search uses a stress test with imaging, a CT angiogram, or an invasive angiogram — and where the anatomy suggests that restoring blood flow would help the pump, revascularisation becomes part of the treatment of the failure rather than a separate matter.

Cardiac magnetic resonance is used when the muscle itself is the question rather than the arteries. It distinguishes scar from inflammation from infiltration, it identifies the patterns that belong to specific cardiomyopathies, and it is the reason some patients who would otherwise be labelled simply as heart failure receive a specific diagnosis — and with it a specific treatment. It is not part of every assessment; it is requested when the answer would change the plan.

Invasive assessment has two roles. Coronary angiography is performed before valve or complex device work, and where the anatomy needs to be known precisely rather than inferred. Right heart catheterisation — measuring the pressures inside the heart directly — is used when the pressures are disputed, when the clinical picture and the echo disagree, or when a decision about advanced options needs numbers rather than estimates.

What a complete assessment should answer

Whether it is read in a clinic in Foshan or sent as a second opinion, a heart failure assessment is complete when it can answer five questions in writing. Anything less leaves the treatment plan resting on an assumption.

  • Which phenotype is this? The ejection fraction, and with it the group of treatments that applies — reduced, mildly reduced, preserved, or improved on treatment.
  • What is causing it? Coronary disease, valve disease, hypertension, a cardiomyopathy, a rhythm problem, or a combination — each with the evidence that supports the label rather than the label alone.
  • What is the state right now? How congested the patient is and how well perfused, expressed in signs, weight and function rather than in adjectives.
  • What is reversible? Iron deficiency, thyroid disease, an active rhythm problem, ischaemia that a procedure could address, valve disease that could be repaired, alcohol or a drug that could be stopped.
  • What is the plan, and what does follow-up look like? The medicines and their starting doses, the weight to be recorded, the symptoms that mean "call us", the rehabilitation referral, and when the next review happens.

Frequently Asked Questions

Is a blood test on its own enough to diagnose heart failure?

No. The natriuretic peptide test is the one blood test aimed at the question "is this heart failure at all", but it answers that question by exclusion rather than by proof. A normal level in a patient who is not yet treated makes the diagnosis unlikely and sends the assessment elsewhere; a raised level points towards the heart without saying which phenotype, how congested the patient is, or what is causing it. Those three answers come from the examination and the echocardiogram, which is why the peptide result is never read on its own.

Will I need a cardiac MRI?

Not necessarily, and it is not a routine test. A cardiac MRI is requested when the muscle itself is the open question: when the pump is weak and the arteries do not explain it, when the pattern of damage suggests an infiltrative or inflammatory process, or when a family history raises the possibility of an inherited cardiomyopathy. Its value is that it can turn a general diagnosis into a specific one, and specificity is what allows a specific treatment. If the arteries, the valves and the rhythm already explain the picture, the MRI usually adds little.

How often does the ejection fraction need to be repeated?

There is no useful calendar interval — the repeat is driven by a question. It is re-measured when the symptoms have changed in a way the last number does not explain, after a meaningful change in treatment such as the introduction or up-titration of the medicines that support the pump, before a decision about a device, and after any event that could have damaged more muscle. Repeating it routinely in a stable patient mostly produces noise, because the measurement varies with blood pressure, fluid and medication.

Is there a test that shows the problem only when I exercise?

Yes, and for some patients it is the decisive one. In the preserved phenotype the ventricle can look normal at rest and only misbehave under load: pressures rise abnormally, and the patient becomes breathless at a workload that should be comfortable. Exercise testing — with echocardiography or with invasive pressure measurement during exercise, or a cardiopulmonary exercise test that measures how the body uses oxygen — brings that out. The same tests are used to assess ischaemia, and to prescribe exercise safely in rehabilitation.

Ask which question your test was answering

Send the echocardiogram report with the ejection fraction and the wall-motion findings, the electrocardiograms, the latest bloods and the medication list with doses. A cardiology team will tell you which phenotype the report describes, which questions it leaves open, and which test would close them — so that nothing is repeated simply because it was not sent.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*